Adopting evolving computer system tools like artificial intelligence and machine learning in managed care pharmacies have resulted in efficiency when addressing the challenges they are faced with, according to Jessica Hatton, PharmD, BCACP, associate vice president of Pharmacy at CareSource and Nick Trego, PharmD, senior vice president of Clinical Analytics and Client Services at HealthPlan Data Solutions, Inc.
The interpretation and reading of pharmacy benefit manager contracts, as well monitoring 100% of pharmacy claims, pose to be some of the biggest challenges in the managed care pharmacy space.
However, adopting evolving computer system tools like artificial intelligence and machine learning in managed care pharmacies have resulted in efficiency when addressing these challenges, according to Jessica Hatton, PharmD, BCACP, associate vice president of Pharmacy at CareSource and Nick Trego, PharmD, senior vice president of Clinical Analytics and Client Services at HealthPlan Data Solutions, Inc.
Both Hatton and Trego presented on these tools and their benefits in the PBM space during this year’s AMCP Nexus conference in Orlando.
Though AI is still developing daily, one of its few subsets – machine learning (ML) — is assisting machines to extract knowledge from data and learn autonomously. These tools together allow users to greatly increase productivity and performance accuracy.
As mentioned, AI and ML are addressing the challenges associated with PBM contract reading.
For example, the volume and complexity of contracts, which can often contain key “adjudication concepts in single sentences,” can be efficiently managed through these technologies, Hatton shared.
Currently, these contracts are done by hand and have a prevalence of being disorganized. These factors lead to avoidance by plans who often limit interactions with contracts overall.
Through experience, the pair shared that integration of AI and ML in contract reading addresses these challenges through:
The next challenge addressed by these tools is the monitoring of 100% of pharmacy claims, a task traditionally associated with a high volume monthly, they’re complex, variable logic and custom plan designs. Currently, PBMs’ methods involve cursory reviews, partial monitoring, or reliance on annual audits.
Hatton and Trego highlighted AI and ML tools are efficient in managing PBM claims through:
Hatton also shared real-life situations CareSource experienced where AI and ML solved problems in the pharmacy space.
For example, in an insulin copay caps case study, the implementation of state laws regarding insulin copay limits posed a challenge requiring custom coding changes. An AI and ML system identified errors in copay adjudication, ensuring quick correction, compliance with state laws, and the prevention of future errors.
In another case study regarding COVID testing mandates, the rapid integration of CMS coverage for over-the-counter COVID-19 tests required short notice for coding changes. AI/ML models effectively monitored testing logic, identifying discrepancies and ensuring adherence to the initiative, in result minimizing unnecessary plan costs.
Beyond contract reading and claims monitoring, the pair shared that AI and ML also find use in member engagement, customer service, and predictive modeling for targeted outreach. In addition, these tools can enhance member interactions, connect with the most at-risk patients based on social determinants of health, assist in formulary management and base modeling on a plan's unique population makeup.
Addressing the Challenges of AI is Imperative | AMCP Nexus 2024
October 22nd 2024There is a need for strict policies regarding the use of AI in the managed care space, according to Douglas S. Burgoyne, Pharm.D., MBA, FAMCP, adjunct associate professor at the University of Utah College of Pharmacy.
Read More
In the Scope of Virtual Health and the Future of “Website” Manner, Per Ateev Mehrotra
August 10th 2023Briana Contreras, an editor of Managed Healthcare Executive, had the pleasure of catching up with MHE Editorial Advisory Board Member, Ateev Mehrotra, MD, MPH, who is a professor of healthcare policy at Harvard Medical School and an Associate Professor of Medicine and Hospitalist at Beth Israel Deaconess Medical Center.
Listen
Technology can help address the complexities of specialty medications by automating processes and enabling proactive interventions to ensure patients stay on their critical therapies, according to Kristen Whelchel, Pharm.D., CSP, Research and Patient Care Improvement Pharmacist with Vanderbilt Specialty Pharmacy's Department of Health Outcomes and Research.
Read More
How Technology Benefits Specialty Pharmacy | AMCP 2024
October 18th 2024Kristen Whelchel, Pharm.D., CSP, Research and Patient Care Improvement Pharmacist with Vanderbilt Specialty Pharmacy's Department of Health Outcomes and Research, explains how technology identifies at-risk patients, coordinates medication refills and more.
Read More
Cancer’s Reign Over the Drug Development Pipeline Continues| AMCP Nexus 2024
October 18th 2024The FDA has already made more than a dozen cancer drug approval decisions this year and more expected in the next several months and in early 2025, according to Kaelyn Boss, who gave an oncology drug pipeline talk at the 2024 AMCP Nexus meeting this week.
Read More